AtlasPROfilax® is available around the world in many languages. Please select your region to switch to another website.
Author: Dr. Victoria Eugenia Gutiérrez Navas, D.D.S Orto Spec.
Place: Bucaramanga, Santander (Colombia)
Study conducted: 2012-2013
Published in: USTASALUD indexed magazine. Official university publication of the Faculty of Dentistry of the Universidad Santo Tomás, Colombia. Vol. 12. no. 2 July - December 2013, ISSN 1692-5106.
Keywords: atlasprofilax, therapy, TMJ, dysfunction, temporomandibular
Abstract: The aim of the present work was to describe the effect of AtlasPROfilax® therapy on symptoms related to temporomandibular dysfunction (TMD), bruxism and on mandibular deviations during the opening and closing trajectory in a cohort of patients. Methodology: A descriptive observational study was carried out to follow up 151 patients who attended the control 30 or 40 days after the therapy was performed; in addition, a sub-sample of 71 patients was taken and analyzed by photographic means. Sociodemographic and clinical variables reported by the patient were taken (pain, noise, jump, blockage, opening limitation and bruxism) and clinical variables taken from the photographic analysis (midline deviation in occlusion, opening and its difference). AtlasPROfilax® therapy reduced TMD related symptoms and also line deviation
The results of the study are not yet available, but a Controlled Clinical Trial (CCT) with a follow-up of three and six months is required for a better evaluation of the effectiveness of this therapeutic alternative.